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Abstract
Background: Diamond-Blackfan anemia (DBA) is a lineage specific and congenital erythroblastopenia. The disease is
associated with mutations in genes encoding ribosomal proteins resulting in perturbed ribosomal subunit biosynthesis. The
RPS19 gene is mutated in approximately 25% of DBA patients and a variety of coding mutations have been described, all
presumably leading to haploinsufficiency. A subset of patients carries rare polymorphic sequence variants within the
59untranslated region (59UTR) of RPS19. The functional significance of these variants remains unclear.
Methodology/Principal Findings: We analyzed the distribution of transcriptional start sites (TSS) for RPS19 mRNAs in testis
and K562 cells. Twenty-nine novel RPS19 transcripts were identified with different 59UTR length. Quantification of expressed
w.t. 59UTR variants revealed that a short 59UTR correlates with high levels of RPS19. The total levels of RPS19 transcripts
showed a broad variation between tissues. We also expressed three polymorphic RPS19 59UTR variants identified in DBA
patients. The sequence variants include two insertions (c.-147_-146insGCCA and c.-147_-146insAGCC) and one deletion (c.-
144_-141delTTTC). The three 59UTR polymorphisms are associated with a 20–30% reduction in RPS19 protein levels when
compared to the wild-type (w.t.) 59UTR of corresponding length.
Conclusions: The RPS19 gene uses a broad range of TSS and a short 59UTR is associated with increased levels of RPS19.
Comparisons between tissues showed a broad variation in the total amount of RPS19 mRNA and in the distribution of TSS
used. Furthermore, our results indicate that rare polymorphic 59UTR variants reduce RPS19 protein levels with implications
for Diamond-Blackfan anemia.
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Introduction
Diamond-Blackfan anemia (DBA; OMIM #205900) is a rare
congenital bone marrow failure characterized by decreased
numbers or absence of erythroid precursor cells [1]. Approxi-
mately 50–60% of DBA patients carry a mutation in one of nine
ribosomal protein (RP) genes of which RPS19 mutations account
for 25% [2]. A series of .100 coding mutations in the RPS19 gene
have been identified ranging from deletions and insertions of
various sizes, single base substitutions resulting in both non-sense
and missense mutations and splice site mutations [3]. A large
proportion of mutations presumably result in functional haploin-
sufficiency for RPS19 by removing transcription from one allele
(deletions or insertions) or by nonsense mediated mRNA decay
(splice site, non-sense and missense mutations) [4]. A translated
RPS19 protein variant can also mediate haploinsufficiency due to
reduced stability, inappropriate localization to the nucleoli,
reduced affinity to interacting partners and failure to assemble
into the pre-ribosome (missense mutations) [5–7]. Haploinsuffi-
ciency for a ribosomal protein leads to perturbed ribosome subunit
synthesis [8–10] followed by increased cellular stress, cell cycle
arrest and apoptosis [11]. The precise mechanism by which RP
mutations mediate the erythroid specific phenotype in DBA is still
unclear. It has been hypothesized that erythropoiesis is particularly
sensitive to ribosomal protein insufficiency and cellular stress
because of a high proliferative and protein synthesis rate [12].
A few gene variants have been described in the non-coding
59UTR of the RPS19 gene, i.e. in the first exon upstream of the
ATG start codon [13–15]. These variants were initially identified
in a subset of DBA patients and later in healthy individuals but at a
low frequency [14,15]. In addition, targeted resequencing of the
entire RPS19 gene in DBA patients has revealed a number of non-
coding sequence variants and rare polymorphisms localized to
introns and flanking sequences [13,14,16,17]. One of the 59UTR
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processing defects but the RPS19 protein levels appeared
unchanged in erythroid cells from a patient with this variant
[14]. However, it is still unclear if this non-coding sequence variant
is transcribed and if it interferes with the translation of RPS19.I n
addition, the distribution of TSS of w.t. RPS19 have not been
carefully analyzed.
The regulation of ribosomal protein expression is critical for
cellular adaptation to different requirements. It is well established
that the 59UTR of mRNAs is of importance for gene expression by
influencing mRNA stability, subcellular localization, accessibility
to the ribosomes and interaction with the translational machinery
[18,19]. Thus, the 59UTR mediates the adjustment of protein
levels to developmental stages, tissue types and growth rate [20].
Conversely, inappropriate expression of 59UTRs can contribute to
abnormal developmental phenotypes and disease [21–23]. Fur-
thermore, the 59UTR of mRNAs encoding ribosomal proteins
contains a 59TOP sequence which enables fast up- or down-
regulation of RP levels [24,25].
The RPS19 coding sequence and its 59UTR are highly
conserved [7,13]. However, the significance of the rare polymor-
phic 59UTR sequence identified in DBA patients is yet unknown.
We examined the transcription of 59UTR variants and we
hypothesized that they affect RPS19 protein synthesis rate as a
possible contributing mechanism in DBA. We show herein that
the expression of three structural RPS19 59UTR variants leads to a
reduced translation into RPS19. Furthermore, RPS19 uses a
broad range of TSS with effects on RPS19 translation and with
tissue variations.
Materials and Methods
RPS19 expression constructs with different 59UTR variants
RPS19 cDNA clones with three w.t. variants of the 59UTR
(figure 1) were amplified and cloned into the reporter vector
pAcGFP-N1 (Clontech) downstream of the CMV promoter. The
resulting constructs encode fusion proteins consisting of a full
length RPS19 linked to a fluorescent reporter at the C-terminus
(Figure 2A). Three DBA associated 59UTR variants (c.-147_-
146insGCCA, c.-147_-146insAGCC and c.-144_-141delTTTC)
were generated by site directed mutagenesis from the pAcGFP-
N1-382-S19-59UTR clone (INTERMEDIATE clone) with Quick
change II site directed mutagenesis kit (Stratagene) according to
manufacturers recommendations.
Cell culture and transfection
K562 [26], HeLa [27] and HEK293 [28] cells were cultured in
RPMI1640 medium supplemented with 10% fetal calf serum,
2 mM L-glutamine and 20 IU penicillin/streptomycin (all Invi-
trogen) at 37uC with 5% CO2 in a humidified environment. Cells
were transfected in 10 cm dishes with 5 mg of the respective vector
using Lipofectamine 2000 H following manufacturer’s protocols.
Transfected cells were checked for expression of GFP by
fluorescence microscopy and harvested using a cell scraper. Cells
were collected by centrifugation.
RNA isolation and quantitative RT/PCR
Total RNA was isolated from K562, HeLa and HEK293 cells
using TrizolH reagent (Invitrogen). Quality of RNA was checked
using the Agilent RNA 6000 nano kit and the Agilent 2100
bioanalyser according to manufacturer’s instructions. RNA
samples from a panel of different primary tissues were purchased
(Human total RNA master panel #636643; Clontech). cDNA was
synthesized with M-MULV reverse transcriptase (MBI Fermentas)
using random hexamer primers and 2 mg of total RNA following
manufacturer’s recommendations. Quantitative real-time PCR
was performed in triplicates using platinum SYBR green qPCR
supermix UDG (Invitrogen) according to the protocol supplied by
the manufacturer. Primer sequences and PCR conditions used to
quantify w.t. RPS19 mRNA with different 59UTRs are available
upon request.
59 Rapid Amplification of cDNA ends (59 RACE)
59RACE was performed with 1 mg of total RNA using the
GeneRacerH kit (Invitrogen) according to manufacturer’s recom-
mendation. Initially, the RNA was treated with DNase I to clean
the samples from any genomic DNA. First strand cDNA synthesis
was carried out with GeneRacer Oligo(dT) primer and Superscript
RT III RACE ready cDNA kit. For amplification of the cDNA
end we used the 59GeneRacer forward primer included in the kit
and RPS19 specific reverse primer. The PCR product was cloned
into a TOPO-TA vector (Invitrogen) and randomly picked
individual clones were sequenced.
Western blotting
HEK293T and K562 cells were lysed in RIPA buffer
supplemented with MG132 proteasome inhibitor (SIGMA),
phosphatase inhibitor cocktail 1 (SIGMA), 0.1 mM Sodium
vanadate (SIGMA) and protease inhibitor cocktail (SIGMA). Cell
lysates were separated on a 10% Bis-Tris SDS-PAGE (NuPage gel;
Invitrogen), and transferred to PVDF Immobilon-FL membranes
(Millipore). Membranes were hybridized with primary antibodies
against GFP (Clontech) and b-actin (Abcam). Proteins detected by
the antibodies were visualized using Alexa Fluor 680 (a-rabbit) and
IRD 800 labeled (a-mouse) secondary antibodies (Molecular
probes and LiCor Bioscience, respectively). Western blots were
analyzed using the OdysseyH infrared imaging system determining
integrated intensities, using b-actin as a normalization control as
described previously [29].
Results
Multiple transcript variants of the RPS19 gene
The RPS19 gene spans a genomic region of 11.5 Mb on
chromosome 19q and consists of 6 exons [13]. The first exon is
untranslated and the start codon is located in the immediate
beginning of exon 2. Ribosomal protein S19 exists in one single
form consisting of 145 amino acids. Six variants of the RPS19
transcript have been described with differences only in length of
the 59UTR from the use of alternate transcription initiation sites
[7,13,30,31]. This prompted us to search for additional RPS19
transcript variants and to analyse their effect on RPS19
expression. We performed cDNA 59RACE with RNA from
K562 cells and testis and we determined the transcript sizes and
their transcriptional start sites. We identified altogether 31
alternative RPS19 transcripts with 59UTRs ranging from 32 to
467 nucleotides. Twenty-nine transcript variants are yet unde-
scribed (figure 1A). The distribution of the RPS19 59UTR length
appeared to be different when comparing randomly picked clones
from K562 cells and testis, respectively (figure 1). Clones from
testis had a distribution towards longer 59UTRs with the longest
clone spanning 467 nucleotides, extending about 100 nucleotides
beyond the previously reported longest RPS19 transcript (Gene
bank #BC018616). Longer RPS19 59UTRs appear highly
structured as predicted by the RNA secondary structure prediction
program Mfold (data not shown).
We then analyzed the relative expression of three groups of
RPS19 transcripts with different 59UTRs on mRNA from a panel
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HeLa by quantitative real time PCR. Three specific primer pairs
were designed that generate amplicons from the RPS19 59UTR
corresponding to nucleotide positions 203 to +89 (amplicon A),
2350 to 2239 (amplicon B) and 2449 to 2354 (amplicon C),
respectively (figure 1B). Quantification of the RT-PCR products
revealed different patterns of 59UTRs when comparing different
tissues and cell lines (1C and D). Transcripts detected by the
shortest amplicon (amplicon A) are predominant in all tissues
investigated. The expression of longer 59UTRs defined by the
amplicons B and C constitute from ,1% to 17% of the total
amount of RPS19 mRNA (figure 1D). No strong correlation was
observed between the total amount of RPS19 mRNA and the
relative proportions of longer and short 59UTR.
Short RPS19 59UTRs show high translational activity
We made three constructs with RPS19 59UTRs of 35
nucleotides (SHORT; containing the 59TOP sequence), 382
nucleotides (INTERMEDIATE) and 467 nucleotides (LONG),
respectively. Each construct expresses a full-length RPS19. The
constructs were fused with Green fluorescent protein at the
carboxy-terminus (figure 2A) and analyzed when transiently
transfected into HEK293T and K562 cells. The SHORT
59UTR variant is translated 4–6 fold more efficient than the
variant with 59UTRs of 382 nt and .10 fold more efficient than
RPS19 with the 467 nt 59UTR (figure 2B–C). The results were
similar for both cell lines.
DBA associated 59UTR variants affect translational activity
We next investigated the effect on translation of three distinct
polymorphic sequence variants in the 59UTR of RPS19 found in a
subset of patients with DBA. We introduced two insertions (c.-
147_-146insGCCA, c.-147_-146insAGCC) and one deletion (c.-
144_-141delTTTC) into the INTERMEDIATE construct
(Figure 3A) followed by a transient transfection into K562 and
HEK293T cells. The three DBA associated 59UTR variants
reduced the RPS19 levels by approximately 20–30% when
compared to the w.t. INTERMEDIATE construct (figure 3B
and C). A marked reduction in expression (32%) was observed for
the TTTC deletion in both cell lines. The AGCC insertion showed
a 30% reduced expression in HEK293 cells and a 26% reduction
in K562 cells. The GCCA insertion was associated with a 20%
reduction in expression in both cell lines (figure 3B and C). The
RPS19 mRNA levels were similar when comparing cells
transfected with the rare variant constructs to cells transfected
with the w.t. construct.
Discussion
The 59-untranslated region (59UTR) of an mRNA is an
important regulator of translation by influencing e.g. mRNA
stability, sub-cellular localization and translational efficiency [32–
34]. Furthermore, multiple transcriptional start sites and 59UTRs
expressed from a single gene encoding one and the same protein
may regulate gene expression through differential expression with
respect to developmental stages, tissue type and in response to
stimuli [20,35,36]. One element that enables fast up- or down-
regulation of ribosomal proteins in response to nutrient supply is
the 59TOP sequence, a stretch of 4 to 14 pyrimidines following a
Cytidine as the first nucleotide located at the 59end of an mRNA
[37]. This 59TOP sequence is contained in the SHORT 59UTR
variant used for expression analysis in our study and possibly
responsible for fast adaptation of RPS19 levels. The heterogeneous
59UTRs of mRNAs transcribed from a single gene arise from the
use of alternate transcriptional initiation sites and differential RNA
processing [38]. It has been estimated that 10–18% of genes
express alternate 59UTRs by multiple promoter usage. Alternate
untranslated regions determine tissue specific function and their
inappropriate expression can contribute to the development of
abnormal phenotypes and disease [39].
We have characterized the RPS19 59UTR variants with respect
to expression levels, tissue specificity, and translation efficiency.
RPS19 is ubiquitously expressed and mutations in this gene are
associated with DBA. The precise molecular mechanisms behind
the disease remain unknown but we hypothesized that the
expression of different RPS19 59UTR variants may contribute to
the regulation of RPS19 protein levels and, ultimately, to DBA.
We determined the extent of the RPS19 mRNA 59UTR by 59-
RACE on poly(A)+ purified mRNA from testis and K562 cells.
The results show an extensive variation in the transcriptional start
sites with .30 different 59UTRs of which 29 are novel. The total
amount of RPS19 mRNA varied considerably between tissues and
we observed up to 10-fold differences. Interestingly, bone marrow
shows relatively low level of total RPS19 transcripts when
compared to several other primary tissues analyzed. We then
investigated the distribution of 59UTR variants in different tissues.
Transcripts were divided into three groups containing a 59UTR of
at least 3 nt, 350 nt and 449 nt, respectively. Our data indicate
clear differences in the distribution of RPS19 59UTRs when
comparing different tissues. The amplicon corresponding to the
shorter 59UTR (amplicon A) constituted between 83% to .99%
of RPS19 transcripts but without correlation to the variation in
total amounts of RPS19 mRNA.
To get a better insight into the translational regulation of RPS19
59UTR variants we investigated the RPS19 levels expressed from
constructs with three distinct 59UTRs length. The SHORT
59UTR variant, spanning a 35 bp 59UTR, is translated four to ten
fold more efficiently than the two longer variants with 59UTRs of
382 bp and 467 bp, respectively. This is also consistent with the
analysis of variable 59UTR length of other genes [34,36]. A
possible explanation is that the SHORT variant exhibits a less
complex secondary structure, facilitating scanning by the transla-
Figure 1. Transcriptional start sites and tissue expression of RPS19 variants. (A) RPS19 59UTR variants in testis and K562 cells. Schematic
presentation of 39 different RPS19 59UTRs identified of which 29 are yet undescribed. 59RACE was performed with 1 mg of total RNA using the
GeneRacerH kit (Invitrogen) according to manufacturer’s recommendation. The RNA was treated with DNase I to clean samples from genomic DNA.
The 59RACE protocol selected full length G-capped mRNA and ruled out the possibility of partially degraded mRNA. PCR products were cloned into a
TOPO-TA vector (Invitrogen) and 122 clones were picked randomly (83 from testis, 39 from K562 cells) and analyzed by bidirectional sequencing. The
59UTR variants identified are indicated and aligned to the first exon of RPS19 from databases with a known maximum 59UTR of 382 nt (bottom). (B)A
schematic picture of the 59 region of RPS19 cDNA (horizontal line) with relative positions of the start codon and the amplicons generated for
quantification. Primers used to generate amplicons A, B and C for quantitative PCR are shown as arrows (sequences available upon request). (C)
Tissue distribution of total RPS19 as determined by qPCR of amplicon A showing relative expression of RPS19 normalized to b-actin on a panel of
primary human tissues and cell lines. Analyses were run in triplicates and the average is shown for each tissue. (D) Expression of the amplicons B and
C representing longer variants of 59UTR as determined by qPCR and expressed as a percentage of total RPS19 expression determined by amplicon A
shown in (C).
doi:10.1371/journal.pone.0017672.g001
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longer 59UTRs may be related to the more complex secondary
structures, making the transcripts less accessible for translation.
The functional significance of the longer RPS19 59UTRs is
unclear, but may be of importance for 59TOP independent
translation providing baseline amounts of RPS19. The shorter
variants could in this case be used for a fast adaptation of RPS19
levels in response to cellular needs. In combination, our
observations suggest a large variation in RPS19 mRNA levels
between tissues as well as in TSS used. The predominant and
shorter 59UTRs are more efficiently translated and may directly
reflect the levels of RPS19.
We then analyzed the effect on translation of rare sequence
variants in the RPS19 59UTR found in subsets of DBA patients.
We confirmed that the polymorphic 59UTR variants are indeed
transcribed and we hypothesized that these transcripts affect
translational efficiency. We therefore investigated the RPS19 levels
expressed from constructs with each of the two insertions (c.-147_-
146insGCCA, c.-147_-146insAGCC) or the deletion (c.-144_-
141delTTTC), respectively. All three variants result in significantly
Figure 3. Structural variants in the RPS19 59UTR associated with
Diamond-Blackfan anemia affect translational efficiency. (A)
Three DBA associated 59UTR variants (c.-147_-146insGCCA, c.-147_-
146insAGCC and c.-144_-141delTTTC), were generated by site directed
mutagenesis from the pAcGFP-N1-382-S19-59UTR clone (i.e. the
‘‘INTERMEDIATE’’ w.t. construct of 382 nt) using the Quick change II
site directed mutagenesis (Stratagene) kit. (B) Western blot of total
protein preparations isolated from transfected HEK293T and K562 cells
performed as for figure 2B. The constructs express each of the three
structural 59UTR variants. (C) Diagram showing the relative levels of
RPS19 expressed from the three constructs in 293T and K562 cells,
respectively. Quantification was made from Western blot analysis
illustrated in (B). The expression from the w.t. ‘‘INTERMEDIATE’’
construct was used as a control and is set to 100.
doi:10.1371/journal.pone.0017672.g003
Figure 2. Short RPS19 59UTR translates into more RPS19. (A)
Sequences corresponding to three w.t. variants of the RPS19 mRNA
including a 35 nt (SHORT), 382 nt (INTERMEDIATE) and 467 nt (LONG)
59UTR, respectively, were introduced into the fluorescent reporter
vector pAcGFP-N1 (Clontech) under the CMV promoter. The expressed
fusion proteins consist of a full length RPS19 linked to green fluorescent
protein (GFP). (B–C) RPS19 protein levels vary with different RPS19
59UTR length. HEK293T and K562 cells were transfected with 5 mgo f
vector DNA from each of the three 59UTR variants using Lipofectami-
neH2000 (Invitrogen). After 48 h, cells were assayed for expression of
recombinant protein by fluorescence microscopy and stored at 220uC
for further analysis by Western blot (B). (C) Diagram illustrating the
relative expression of the three w.t. constructs in HEK293T and K562
cells, respectively. Quantification is based on Western blot analysis in (B)
and the expression of RPS19-GFP fusion protein was normalized to b-
actin.
doi:10.1371/journal.pone.0017672.g002
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type sequence. A possible explanation is that the mutation causes
the mRNA to adopt a more complex secondary structure that
represses translation. It is noteworthy that the observed reduction
in RPS19 levels in our cell-systems is related to a relatively large
proportion of the ‘‘INTERMEDIATE’’ RPS19 transcripts con-
taining each of the specific 59UTR variants. Still, the observed
effects of the three 59UTR variants associated with DBA do not
result in haploinsufficiency and, accordingly, the impact on RPS19
levels in vivo would depend on the relative amounts of longer
RPS19 mRNAs. Although these 59UTR variants may lead to
suboptimal conditions for growth and differentiation of tissues
sensitive to reduced RPS19 levels it is likely that additional factors
are required for overt clinical forms of DBA. Our results are
consistent with the increased ratio of 21S/18S pre-rRNAs
associated with the c.-147_-146insGCCA variant observed
previously [14]. Failure to detect reduced RPS19 levels in that
study may be due to low abundance of longer transcripts and/or
minor changes in RPS19 levels in the cells analyzed.
Our combined findings suggest complex regulatory mechanisms
of RPS19. RPS19 uses a broad range of TSS with tissue specific
differences and shorter 59UTRs are more efficiently translated.
We also show that DBA associated 59UTR variants of RPS19 are
less efficiently translated. Further investigations are now required
to understand how RPS19 is regulated in different tissues both at
the transcriptional and the translational level. These studies may
clarify the distribution and levels of RPS19 59UTR variants as well
as RPS19 protein levels at different stages of erythropoiesis. Thus,
analysis of the RPS19 TSS used in erythroid precursor cells may
provide valuable information in search for molecular mechanisms
behind DBA.
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